Characterization of multiple myeloma clonal cell expansion and stromal Wnt/β-catenin signaling in hyaluronic acid-based 3D hydrogel

In Vivo

Volumn 28, Issue 1, 2014, Pages 67-73

  Narayanan, Narayanan K ^a   Duan, B I N ^b   Butcher, Jonathan T ^b   Mazumder, Amitabha ^a,c   Narayanan, Bhagavathi A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Operations Research and Industrial Engineering   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Colony forming units (CFU); Methacrylated gelatin (Me Gel); Methacrylated hyaluronic acid (Me HA); Multiple myeloma (MM); Three dimensional (3D); Wnt; catenin

Indexed keywords

BETA CATENIN; CYTOKINE; HYALURONIC ACID; METHACRYLIC ACID; WNT PROTEIN;

ARTICLE; BONE MARROW STROMA CELL; CANCER CELL; CELL CULTURE; CELL EXPANSION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HYDROGEL; MULTIPLE MYELOMA; PHENOTYPE; PROTEIN EXPRESSION; RIGIDITY; SIGNAL TRANSDUCTION; THREE DIMENSIONAL CELL CULTURE; WNT SIGNALING PATHWAY; CELL CLONE; COLONY FORMING UNITS (CFU); CULTURE TECHNIQUE; GENETICS; METABOLISM; METHACRYLATED GELATIN (ME-GEL); METHACRYLATED HYALURONIC ACID (ME-HA); MULTIPLE MYELOMA (MM); PATHOLOGY; THREE-DIMENSIONAL (3D); WNT; Β-CATENIN;

COLONY FORMING UNITS (CFU); METHACRYLATED GELATIN (ME-GEL); METHACRYLATED HYALURONIC ACID (ME-HA); MULTIPLE MYELOMA (MM); THREE-DIMENSIONAL (3D); WNT; Β-CATENIN;

CELL CULTURE TECHNIQUES; CLONE CELLS; HUMANS; HYALURONIC ACID; HYDROGEL; MULTIPLE MYELOMA; WNT SIGNALING PATHWAY;

EID: 84906927397     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Haycock JW: 3D cell culture: a review of current approaches and techniques. Methods Mol Biol 695: 1-15, 2011.
2. Nyga A, Cheema U and Loizidou M: 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal 5(3): 239-248, 2011.
3. Bataille R: New insights in the clinical biology of multiple myeloma. Semin Hematol 34(1 Suppl 1): 23-28, 1997.
4. Bataille R and Harousseau JL: Multiple myeloma. N Engl J Med 336(23): 1657-1664, 1997.
5. Bataille R, Manolagas SC and Berenson JR: Pathogenesis and management of bone lesions in multiple myeloma. Hematol Oncol Clin North Am 11(2): 349-361, 1997.
6. Caligaris-Cappio F, Bergui L, Gregoretti MG, Gaidano G, Gaboli M, Schena M, Zallone AZ and Marchisio PC: Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 77(12): 2688-2693, 1991.
7. Vincent T and Mechti N: Extracellular matrix in bone marrow can mediate drug resistance in myeloma. Leuk Lymphoma 46( 6): 803-811, 2005.
8. Asosingh K, Radl J, Van Riet I, Van Camp B and Vanderkerken K: The 5TMM series: a useful in vivo mouse model of human multiple myeloma. Hematol J 1(5): 351-356, 2000.
9. Yaccoby S, Barlogie B and Epstein J: Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations. Blood 92(8): 2908-2913, 1998.
10. Niemeyer P, Mehlhorn A, Jaeger M, Kasten P, Simank HG, Krause U and Sudkamp NP: [Adult mesenchymal stem cells for the regeneration of musculoskeletal tissue]. MMW Fortschr Med 146(Suppl 3-4): 107-113, 2004.
11. Yang XB, Bhatnagar RS, Li S and Oreffo RO: Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng 10(7-8): 1148-1159, 2004.
12. Jelinek DF: Myeloma research goes 3D. Blood 112(7): 2600-2601, 2008.
13. Kirshner J, Thulien KJ, Martin LD, Debes Marun C, Reiman T, Belch AR and Pilarski LM: A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma. Blood 112( 7): 2935-2945, 2008.
14. Duan B, Hockaday LA, Kang KH and Butcher JT: 3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels. J Biomed Mater Res A 101( 5): 1255-1264, 2013.
15. Duan B, Hockaday LA, Kapetanovic E, Kang KH and Butcher JT: Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels. Acta Biomater 9(8): 7640-7650, 2013.
16. Zaman MH, Trapani LM, Sieminski AL, Mackellar D, Gong H, Kamm RD, Wells A, Lauffenburger DA and Matsudaira P: Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci USA 103(29): 10889-10894, 2006.
17. Drury JL and Mooney DJ: Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24(24): 4337-4351, 2003.
18. Jabbari E: Bioconjugation of hydrogels for tissue engineering. Curr Opin Biotechnol 22(5): 655-660, 2011.
19. Kloxin AM, Tibbitt MW and Anseth KS: Synthesis of photodegradable hydrogels as dynamically tunable cell culture platforms. Nat Protoc 5(12): 1867-1887, 2010.
20. Kloxin AM, Tibbitt MW, Kasko AM, Fairbairn JA and Anseth KS: Tunable hydrogels for external manipulation of cellular microenvironments through controlled photodegradation. Adv Mater 22(1): 61-66, 2010.
21. Lee KY and Mooney DJ: Hydrogels for tissue engineering. Chem Rev 101( 7): 1869-1879, 2001.
22. Santos E, Hernandez RM, Pedraz JL and Orive G: Novel advances in the design of three-dimensional bio-scaffolds to control cell fate: translation from 2D to 3D. Trends Biotechnol 30(6): 331-341, 2012.
23. Narayanan BA, Doudican NA, Park J, Dasgupta R, Narayanan NK, Xu D and Mazumder A: Antagonistic effect of small molecule inhibitors of Wnt/innodatabeta-catenin in Multiple Myeloma. Anticancer Research 32(11): 4697-4707, 2012.
24. Narayanan BA, Narayanan NK, Davis L and Nargi D: RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor. Mol Cancer Ther 5(5): 1117-1125, 2006.
25. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302): 964-967, 1997.
26. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA and Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348(7): 593-600, 2003.
27. Gupta D, Treon SP, Shima Y, Hideshima T, Podar K, Tai YT, Lin B, Lentzsch S, Davies FE, Chauhan D, Schlossman RL, Richardson P, Ralph P, Wu L, Payvandi F, Muller G, Stirling DI and Anderson KC: Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia 15(12): 1950-1961, 2001.
28. Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D and Anderson KC: Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood 82(12): 3712-3720, 1993.
29. Butcher JT, Goodwill AG and Frisbee JC: The ex vivo isolated skeletal microvessel preparation for investigation of vascular reactivity. J Vis Exp 62: 2012.